Literature DB >> 24840811

PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN.

Bin Li1, Terry J Smith.   

Abstract

CONTEXT: TSH provokes expression of inflammatory genes in CD34(+) fibrocytes. These cells appear to infiltrate the orbit in Graves' disease (GD), where they putatively become the CD34(+) orbital fibroblast subset (GD-OF). This may have importance in solving the pathogenesis of thyroid-associated ophthalmopathy. The IL-1 family is targeted by TSH in fibrocytes and OFs by inducing secreted IL-1 receptor antagonist (IL-1RA) and intracellular IL-1RA in a cell-specific pattern. Phosphoinositide 3-kinase (PI3K) mediates several TSH actions in thyroid. This pathway is modulated by phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Vanishingly little is known currently about TSHR signaling to IL-1RA expression in nonthyroidal cells. Furthermore, factors modulating TSH action in these cells are largely unexplored.
OBJECTIVES: To characterize intermediate signaling between TSHR and IL-1RA in fibrocytes and GD-OFs and to begin to identify the proximate regulators of TSHR signaling in nonepithelial, extrathyroidal cells as a strategy for developing therapies for thyroid-associated ophthalmopathy. DESIGN/SETTING/PARTICIPANTS: Fibrocytes and GD-OFs were collected and analyzed from healthy individuals and those with GD in an academic clinical practice. MAIN OUTCOME MEASURES: Real-time PCR, Western blot analysis, cell transfections, and chromatin immunoprecipitation analysis.
RESULTS: TSH induces IL-1RA in fibrocytes and GD-OFs by activating the PI3K/AKT pathway. Interrupting either PI3K or AKT with small molecule inhibitors or by knocking down their expression with targeting small interfering RNA attenuates the actions of TSH. OFs exhibit greater basal PTEN activity and lower constitutive AKT phosphorylation than do fibrocytes. Patterns of PTEN induction diverge in the two cell types.
CONCLUSIONS: The current findings identify the PI3K/AKT pathway as critical to the induction by TSH of IL-1RA in fibrocytes and GD-OFs. Furthermore, PTEN modulates the amplitude of the induction. In GD-OFs, relatively high basal PTEN levels prevent secreted IL-1RA expression or release. Knocking down PTEN allows GD-OFs to exhibit a pattern of IL-1RA expression resembling fibrocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24840811      PMCID: PMC4154109          DOI: 10.1210/jc.2014-1257

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  42 in total

1.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

2.  Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes.

Authors:  J Chesney; C Metz; A B Stavitsky; M Bacher; R Bucala
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

3.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

Review 4.  Phospholipid signaling.

Authors:  N Divecha; R F Irvine
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

5.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

6.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

7.  Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta elicit opposing effects on Rap1GAP stability.

Authors:  Oxana M Tsygankova; Elena Feshchenko; Peter S Klein; Judy L Meinkoth
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

8.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

9.  Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells.

Authors:  Gianluca Tell; Alex Pines; Franco Arturi; Laura Cesaratto; Eileen Adamson; Cinzia Puppin; Ivan Presta; Diego Russo; Sebastiano Filetti; Giuseppe Damante
Journal:  Endocrinology       Date:  2004-07-01       Impact factor: 4.736

10.  The expression of the thyroid-stimulating hormone (TSH) receptor and the cAMP-dependent protein kinase RII beta regulatory subunit confers TSH-cAMP-dependent growth to mouse fibroblasts.

Authors:  Antonio Porcellini; Samantha Messina; Giorgia De Gregorio; Antonio Feliciello; Annalisa Carlucci; Mariavittoria Barone; Antonietta Picascia; Antonio De Blasi; Enrico V Avvedimento
Journal:  J Biol Chem       Date:  2003-08-05       Impact factor: 5.157

View more
  15 in total

Review 1.  TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Authors:  Terry J Smith
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

Review 2.  IGF1 receptor and thyroid-associated ophthalmopathy.

Authors:  Michelle Mohyi; Terry J Smith
Journal:  J Mol Endocrinol       Date:  2017-12-22       Impact factor: 5.098

3.  Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy.

Authors:  Roshini Fernando; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 4.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

Review 5.  Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

6.  Teprotumumab Treatment for Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith
Journal:  Eur Thyroid J       Date:  2020-07-13

Review 7.  New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.

Authors:  Qiongyao He; Hui Dong; Minmin Gong; Yujin Guo; Qingsong Xia; Jing Gong; Fuer Lu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

8.  The Role of the Immune Response in the Pathogenesis of Thyroid Eye Disease: A Reassessment.

Authors:  James T Rosenbaum; Dongseok Choi; Amanda Wong; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant K Parekh; Gerald J Harris; Michael Kazim; Payal J Patel; Valerie A White; Peter J Dolman; Deepak P Edward; Hind M Alkatan; Hailah Al Hussain; Dinesh Selva; R Patrick Yeatts; Bobby S Korn; Don O Kikkawa; Patrick Stauffer; Stephen R Planck
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

9.  TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.

Authors:  Hong Chen; Shannon J C Shan; Tünde Mester; Yi-Hsuan Wei; Raymond S Douglas
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

10.  Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks.

Authors:  Jennifer Enciso; Hector Mayani; Luis Mendoza; Rosana Pelayo
Journal:  Front Physiol       Date:  2016-08-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.